In glioma, resistance to TMZ and therapeutic failure are mainly determined by overexpression of O6-methylguanine-DNA methyltransferase (MGMT), an enzyme that plays a key role in reverting the alkylation process done by TMZ [39]. The gene discussed is MGMT; the disease is glioma.